Get started
222

LUYE PHARMA GROUP LIMITED

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

2186 chart


Full chart

2186 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪10.46 B‬HKD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
12.77
Basic EPS (TTM)
0.22HKD
Net income (FY)
‪588.53 M‬HKD
Revenue (FY)
‪6.79 B‬HKD
Shares float
‪1.95 B‬
Beta (1Y)
0.81

Employees


Employees (FY)
‪5.27 K‬
Change (1Y)
+265 +5.29%
Revenue / Employee (1Y)
‪164.91 K‬HKD
Net income / Employee (1Y)
‪14.30 K‬HKD

About LUYE PHARMA GROUP LIMITED


Sector
Health Technology
CEO
Dian Bo Liu
Headquarters
Yantai
Website
luye.cn
Founded
1994
FIGI
BBG006PTKB26
Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling of pharmaceutical products. It operates through the following segments: Oncology Drugs, Cardiovascular System Drugs, Alimentary Tract and Metabolism Drugs, and Others. The company was founded on June 8, 1994 and is headquartered in Yantai, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

2186 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 2186 is 2.80 HKD — it has decreased by −2.12% in the past 24 hours. Watch LUYE PHARMA GROUP LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange LUYE PHARMA GROUP LIMITED stocks are traded under the ticker 2186.
2186 stock has fallen by −9.48% compared to the previous week, the month change is a −13.71% fall, over the last year LUYE PHARMA GROUP LIMITED has showed a −26.89% decrease.
We've gathered analysts' opinions on LUYE PHARMA GROUP LIMITED future price: according to them, 2186 price has a max estimate of 4.00 HKD and a min estimate of 3.00 HKD. Watch 2186 chart and read a more detailed LUYE PHARMA GROUP LIMITED stock forecast: see what analysts think of LUYE PHARMA GROUP LIMITED and suggest that you do with its stocks.
2186 reached its all-time high on Oct 30, 2014 with the price of 11.54 HKD, and its all-time low was 1.88 HKD and was reached on Oct 28, 2022. View more price dynamics on 2186 chart.
See other stocks reaching their highest and lowest prices.
2186 stock is 2.55% volatile and has beta coefficient of 0.81. Track LUYE PHARMA GROUP LIMITED stock price on the chart and check out the list of the most volatile stocks — is LUYE PHARMA GROUP LIMITED there?
Today LUYE PHARMA GROUP LIMITED has the market capitalization of ‪10.65 B‬, it has decreased by −2.66% over the last week.
Yes, you can track LUYE PHARMA GROUP LIMITED financials in yearly and quarterly reports right on TradingView.
LUYE PHARMA GROUP LIMITED is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
2186 net income for the last half-year is ‪420.27 M‬ HKD, while the previous report showed ‪413.37 M‬ HKD of net income which accounts for 1.67% change. Track more LUYE PHARMA GROUP LIMITED financial stats to get the full picture.
LUYE PHARMA GROUP LIMITED dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 5, 2024, the company has ‪5.27 K‬ employees. See our rating of the largest employees — is LUYE PHARMA GROUP LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LUYE PHARMA GROUP LIMITED EBITDA is ‪2.23 B‬ HKD, and current EBITDA margin is 26.37%. See more stats in LUYE PHARMA GROUP LIMITED financial statements.
Like other stocks, 2186 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LUYE PHARMA GROUP LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LUYE PHARMA GROUP LIMITED technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LUYE PHARMA GROUP LIMITED stock shows the sell signal. See more of LUYE PHARMA GROUP LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.